The Stock Medicines Regulation 2005 was subject to staged repeal under the requirements of the Subordinate Legislation Act 1989. Under this Act, most regulations are subject to automatic repeal every five years. Regulations are generally reviewed, and allowed to lapse, or are remade with or without amendment. 

The Stock Medicines Regulation 2010 commenced on 1 September 2010 after online notification on the NSW Legislation website on 20 August 2010. The Regulation is made under the Stock Medicines Act 1975. The object of this Act is to protect human health by ensuring that illegal or unsuitable levels of chemical residues from stock medicines do not transfer to the human food chain. The Act also facilitates international trade by helping ensure that livestock products for export markets comply with chemical residue requirements of international trading partners.

The Stock Medicines Regulation assists in achieving the objectives of the Act by limiting advertising of some stock medicines, prescribing requirements relating to notification of the use of stock medicines to buyers of animal products, adding to the major food producing species defined under the Act, and prescribing the stock medicine records to be kept by veterinarians.

The draft Regulation and Regulatory Impact Statement (RIS) (114kb PDF) were publicly exhibited between 10 May and 11 June 2010. No submissions were received from public consultation. The Regulatory Impact Statement has been updated (115kb PDF) to reflect the outcome of public consultation, and the Regulation has been made as drafted.

The final Regulation can be viewed on the NSW Legislation website of the NSW Parliamentary Counsel at www.legislation.nsw.gov.au.